These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24215933)

  • 1. Rapid determination of alendronate to quality evaluation of tablets by high resolution ¹H NMR spectroscopy.
    Xie B; Liu A; Fang X; Chen Y; Zhong H
    J Pharm Biomed Anal; 2014 May; 93():73-6. PubMed ID: 24215933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process analytical technology to understand the disintegration behavior of alendronate sodium tablets.
    Xu X; Gupta A; Sayeed VA; Khan MA
    J Pharm Sci; 2013 May; 102(5):1513-23. PubMed ID: 23450666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro determination of the release of alendronic acid from alendronate tablets of different brands during deglutition.
    Lamprecht G
    J Pharm Sci; 2009 Oct; 98(10):3575-81. PubMed ID: 19630066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectroscopic and HPLC methods for the determination of alendronate in tablets and urine.
    Al Deeb SK; Hamdan II; Al Najjar SM
    Talanta; 2004 Oct; 64(3):695-702. PubMed ID: 18969661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo equivalence studies of alendronate monosodium tablets.
    Roldán EJ; Quattrocchi O; Zanetti D; Piccinni E; Tessler J; Caballero LE; Lloret AP
    Arzneimittelforschung; 2005; 55(2):93-101. PubMed ID: 15787276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro disintegration and dissolution and in vivo bioequivalence of two alendronate once-weekly formulations.
    Almeida S; Almeida A; Filipe A; Penedo C; Rocha A; Lainesse A; Vallée F
    Arzneimittelforschung; 2006; 56(2):84-9. PubMed ID: 16572922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate sodium.
    Ananchenko G; Novakovic J; Tikhomirova A
    Profiles Drug Subst Excip Relat Methodol; 2013; 38():1-33. PubMed ID: 23668401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple innovative spectrofluorometric method for the determination of alendronate in bulk and in pharmaceutical tablets.
    Elmalla SF; Mansour FR
    Luminescence; 2019 May; 34(3):375-381. PubMed ID: 30884083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple and rapid high-performance liquid chromatography method for determination of alendronate sodium in beagle dog plasma with application to preclinical pharmacokinetic study.
    Meng J; Meng Q; Zheng L
    Biomed Chromatogr; 2010 Feb; 24(2):169-73. PubMed ID: 19591131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications.
    Dansereau RJ; Crail DJ; Perkins AC
    Curr Med Res Opin; 2008 Apr; 24(4):1137-45. PubMed ID: 18334082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro study of oesophageal adhesiveness of different commercial formulations containing alendronate.
    Shakweh M; Bravo-Osuna I; Ponchel G
    Eur J Pharm Sci; 2007 Aug; 31(5):262-70. PubMed ID: 17576054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans.
    Yun MH; Kwon KI
    J Pharm Biomed Anal; 2006 Jan; 40(1):168-72. PubMed ID: 16095861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ab initio structure determination of anhydrous sodium alendronate from laboratory powder X-ray diffraction data.
    Asnani M; Vyas K; Bhattacharya A; Devarakonda S; Chakraborty S; Mukherjee AK
    J Pharm Sci; 2009 Jun; 98(6):2113-21. PubMed ID: 18781644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(γ-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting.
    de Miguel L; Noiray M; Surpateanu G; Iorga BI; Ponchel G
    Int J Pharm; 2014 Jan; 460(1-2):73-82. PubMed ID: 24211357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton NMR: a new tool for understanding dissolution.
    Coombes SR; Hughes LP; Phillips AR; Wren SA
    Anal Chem; 2014 Mar; 86(5):2474-80. PubMed ID: 24471686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of apomorphine freebase in sublingual tablets by proton nuclear magnetic resonance spectroscopy.
    Tan L; Chin SF; Miner VW; Dong L; Gupta S; Fields SM
    J Pharm Biomed Anal; 2016 Sep; 129():378-382. PubMed ID: 27454089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of alendronate and vitamin D(3) in an alendronate/vitamin D(3) combination tablet.
    Denker AE; Lazarus N; Porras A; Ramakrishnan R; Constanzer M; Scott BB; Chavez-Eng C; Woolf E; Maganti L; Larson P; Gottesdiener K; Wagner JA
    J Clin Pharmacol; 2011 Oct; 51(10):1439-48. PubMed ID: 21148044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of a gastroretentive dosage form composed of chitosan and hydroxyethyl cellulose for alendronate.
    Chen YC; Ho HO; Chiu CC; Sheu MT
    Drug Des Devel Ther; 2014; 8():67-78. PubMed ID: 24403821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative 1H-NMR Method for the Determination of Tadalafil in Bulk Drugs and its Tablets.
    Yang Q; Qiu H; Guo W; Wang D; Zhou X; Xue D; Zhang J; Wu S; Wang Y
    Molecules; 2015 Jul; 20(7):12114-24. PubMed ID: 26147583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of taurine in energy drinks using ¹H NMR.
    Hohmann M; Felbinger C; Christoph N; Wachter H; Wiest J; Holzgrabe U
    J Pharm Biomed Anal; 2014 May; 93():156-60. PubMed ID: 24094700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.